封面
市场调查报告书
商品编码
1966185

全球血管内导管市场规模、份额、趋势和成长分析报告(2026-2034年)

Global Intravascular Catheters Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 151 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计血管内导管市场将从 2025 年的 93.8 亿美元成长到 2034 年的 269 亿美元,2026 年至 2034 年的复合年增长率为 12.42%。

由于心血管疾病盛行率不断上升和住院人数增加,全球血管内导管市场正稳定成长。这些医疗设备对于药物和液体的输注以及血压监测至关重要。外科手术数量的增加和全球急救服务的扩展是推动市场需求的主要因素。此外,导管安全性的提高和感染风险的降低等技术进步也促进了市场扩张。

人口老化、慢性病发病率上升以及新兴国家医疗基础设施的扩张是成长要素。微创手术的日益普及进一步加速了市场成长。产品设计的改进,例如抗菌涂层和更高的柔软性,正在改善患者的治疗效果。已开发国家有利的健保报销政策也促进了市场成长。

随着全球医疗保健服务的改善,预计未来市场将稳定成长。整合即时监测感测器的智慧导管创新有望创造新的机会。更加重视降低医院感染率将推动产品改进。随着医疗保健投资和意识的提高,新兴经济体有望成为关键成长区域。

目录

第一章:引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章 全球血管导管市场:依产品划分

  • 市场分析、洞察与预测
  • 短PIVC
  • 整合/封闭式PIVC

第五章 全球血管内导管市场:依应用领域划分

  • 市场分析、洞察与预测
  • 肿瘤学
  • 胃肠病学
  • 肾臟疾病
  • 感染疾病
  • 其他的

第六章 全球血管内导管市场:依最终用途划分

  • 市场分析、洞察与预测
  • 医院
  • 诊所
  • ASC
  • 居家医疗
  • 其他的

第七章 全球血管内导管市场:依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和分销通路合作伙伴(根据现有资讯)
  • 市场占有率和市场定位分析(基于现有资讯)
  • 供应商情况(基于现有资讯)
  • 策略规划

第九章:公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Abbott
    • BD
    • Boston Scientific Corporation
    • Medtronic
    • Cook
    • Johnson & Johnson Private Limited
    • Smith & Nephew Plc
    • Cardinal Health
    • Terumo Corporation
    • Conavi Medical
    • Edwards Lifesciences Corporation
    • InfraredxInc
    • Getinge AB
    • Coloplast Corp
    • McKesson Medical-Surgical
简介目录
Product Code: VMR11210529

The Intravascular Catheters Market size is expected to reach USD 26.90 Billion in 2034 from USD 9.38 Billion (2025) growing at a CAGR of 12.42% during 2026-2034.

The Global Intravascular Catheters Market has grown steadily due to rising prevalence of cardiovascular diseases and increasing hospital admissions. These devices are essential for administering medications, fluids, and monitoring blood pressure. Growing surgical procedures and emergency care services worldwide have significantly driven demand. Technological advancements have improved catheter safety and reduced infection risks, supporting market expansion.

Key drivers include aging populations, rising chronic disease incidence, and expansion of healthcare infrastructure in emerging economies. Increasing adoption of minimally invasive procedures has further fueled growth. Enhanced product designs with antimicrobial coatings and better flexibility are improving patient outcomes. Favorable reimbursement policies in developed countries also contribute to market growth.

Looking forward, the market is expected to witness consistent growth as healthcare access improves globally. Innovation in smart catheters integrated with sensors for real-time monitoring will create new opportunities. Increasing focus on reducing hospital-acquired infections will drive product improvements. Emerging economies are anticipated to become key growth regions due to healthcare investments and rising awareness.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Short PIVC
  • Integrated/Closed PIVC

By Application

  • Oncology
  • Gastroenterology
  • Renal Disease
  • Infectious Diseases
  • Others
  • By-End-Use
  • Hospitals
  • Clinics
  • ASC
  • Homecare
  • Others

COMPANIES PROFILED

  • Abbott, BD, Boston Scientific Corporation, Medtronic, Cook, Johnson Johnson Private Limited, Smith Nephew plc, Cardinal Health, Terumo Corporation, Conavi Medical, Edwards Lifesciences Corporation, Infraredx, Inc, Getinge AB, Coloplast Corp, McKesson MedicalSurgical

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL INTRAVASCULAR CATHETERS MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Short PIVC Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Integrated/Closed PIVC Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INTRAVASCULAR CATHETERS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Gastroenterology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Renal Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INTRAVASCULAR CATHETERS MARKET: BY BY-END-USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast By-end-use
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. ASC Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Homecare Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL INTRAVASCULAR CATHETERS MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product
    • 7.2.2 By Application
    • 7.2.3 By By-end-use
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product
    • 7.3.2 By Application
    • 7.3.3 By By-end-use
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product
    • 7.4.2 By Application
    • 7.4.3 By By-end-use
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product
    • 7.5.2 By Application
    • 7.5.3 By By-end-use
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product
    • 7.6.2 By Application
    • 7.6.3 By By-end-use
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL INTRAVASCULAR CATHETERS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Abbott
    • 9.2.2 BD
    • 9.2.3 Boston Scientific Corporation
    • 9.2.4 Medtronic
    • 9.2.5 Cook
    • 9.2.6 Johnson & Johnson Private Limited
    • 9.2.7 Smith & Nephew Plc
    • 9.2.8 Cardinal Health
    • 9.2.9 Terumo Corporation
    • 9.2.10 Conavi Medical
    • 9.2.11 Edwards Lifesciences Corporation
    • 9.2.12 InfraredxInc
    • 9.2.13 Getinge AB
    • 9.2.14 Coloplast Corp
    • 9.2.15 McKesson Medical-Surgical